Arcinova Appoints Roger Kilburn as CEO

Arcinova has appointed Roger Kilburn as its new CEO. Source: Arcinova
Arcinova has appointed Roger Kilburn as its new CEO. Source: Arcinova

UK-based contract development and manufacturing organization (CDMO) Arcinova has appointed Roger Kilburn as its new CEO, effective immediately. The previous CEO, Ian Shott, has assumed the position of executive chairman.

Kilburn has more than 25 years of international experience in the pharmaceutical and chemical industries. He has worked in a variety of roles within general management, marketing, sales, manufacturing, projects and engineering. Prior to his most recent position as CEO of IBioIC, Kilburn worked for Johnson Matthey and ICI in business leader positions. He holds a 1st class honors degree in chemical engineering from the University of Glamorgan.

Ian Shott commented, “I am delighted that Roger is taking over this crucial role and certain that his experience leading both Macfarlan Smith in Edinburgh and JM Pharma Services in Boston, Massachusetts gives him an excellent foundation to steer Arcinova through its critical scale up phase, creating a strong and sustainable medium sized enterprise.”

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read